Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse events
ID
Redenšek Trampuž, Sara
(
Author
),
ID
Kristanc, Tilen
(
Author
),
ID
Blagus, Tanja
(
Author
),
ID
Trošt, Maja
(
Author
),
ID
Dolžan, Vita
(
Author
)
PDF - Presentation file,
Download
(279,78 KB)
MD5: C54388CCDE61C42CFE19099F22E0E5FC
URL - Source URL, Visit
https://www.frontiersin.org/articles/10.3389/fnagi.2022.853277/full
Image galllery
Abstract
Vitamin D is a lipid-soluble molecule and an important transcriptional regulator in many tissues and organs, including the brain. Its role has been demonstrated also in Parkinson’s disease (PD) pathogenesis. Vitamin D receptor (VDR) is responsible for the initiation of vitamin D signaling cascade. The aim of this study was to assess the associations of VDR genetic variability with PD risk and different PD-related phenotypes. We genotyped 231 well characterized PD patients and 161 healthy blood donors for six VDR single nucleotide polymorphisms, namely rs739837, rs4516035, rs11568820, rs731236, rs2228570, and rs1544410. We observed that VDR rs2228570 is associated with PD risk (p < 0.001). Additionally, we observed associations of specific VDR genotypes with adverse events of dopaminergic treatment. VDR rs1544410 (GG vs. GA + AA: p = 0.005; GG vs. GA: p = 0.009) was associated with the occurrence of visual hallucinations and VDR rs739837 (TT vs. GG: p = 0.036), rs731236 (TT vs. TC + CC: p = 0.011; TT vs. TC: p = 0.028; TT vs. CC: p = 0.035), and rs1544410 (GG vs. GA: p = 0.014) with the occurrence of orthostatic hypotension. We believe that the reported study may support personalized approach to PD treatment, especially in terms of monitoring vitamin D level and vitamin D supplementation in patients with high risk VDR genotypes.
Language:
English
Keywords:
vitamin D receptor
,
Parkinson’s disease
,
biomarker
,
risk
,
susceptibility
,
adverse events
,
vitamin D
,
polymorphism
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2022
Number of pages:
9 str.
Numbering:
Vol. 14, art. 853277
PID:
20.500.12556/RUL-145377
UDC:
616.8
ISSN on article:
1663-4365
DOI:
10.3389/fnagi.2022.853277
COBISS.SI-ID:
101668611
Publication date in RUL:
19.04.2023
Views:
588
Downloads:
98
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Frontiers in aging neuroscience
Shortened title:
Front. aging neurosci.
Publisher:
Frontiers Media
ISSN:
1663-4365
COBISS.SI-ID:
20576008
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
nevrologija
,
Parkinsonova bolezen
,
receptor vitamina D
,
nevroznanost
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0170
Name:
Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back